Choriocarcinoma is a rare, aggressive gestational trophoblastic disorder with metastatic potential, often presenting
with abnormal bleeding and increasing levels of beta-human chorionic gonadotropin (b-hCG). Diagnosis
is confirmed through histopathologic examination after curettage, and treatment typically involves stagedependent
chemotherapy. This case report concerns a 25-year-old woman with heavy postpartum bleeding,
later diagnosed with choriocarcinoma. Despite initial single-agent chemotherapy, disease progression led to
uterine perforation and hemoperitoneum, requiring emergency surgery. Following recovery, multi-agent
chemotherapy resolved her symptoms. Choriocarcinoma’s rarity and varied presentation make diagnosis challenging,
with lung metastases common. Levels of b-hCG indicate treatment response, and prompt management
combining chemotherapy, monitoring, and surgery is crucial for positive outcomes
Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.